Lerøy invests in US biotech firm

Salmonics

Investment in Salmonics will go towards supporting the company’s development of solutions utilising fish blood

Maine-based Salmonics Inc has confirmed that Lerøy Seafood Group has made a strategic investment in the biotech firm, with the new funding going towards supporting its continued growth and the development of biotechnological solutions utilising fish blood.

Continue this article…

Already subscribed? SIGN IN now

wf_web_image

Sign up for FREE to continue this article!

Want to read more before deciding on a subscription? It only takes a minute to sign up for a free account and you’ll get to enjoy:

  • Weekly newsletters providing valuable news and information on the commercial fishing and aquaculture sector
  • Full access to our news archive
  • Live and archived webinars, podcasts and videos
  • Articles on innovations and current trends in the commercial fishing industry
  • Our extensive archive of data, research and intelligence

Get more free content sign up today

Ready to subscribe? Choose from one of our subscription packages for unlimited access!